Can Vitamin C Prevent Complex Regional Pain Syndrome in Patients with Wrist Fractures?

Zollinger, P. E.; Tuinebreijer, W. E.; Breederveld, R. S.; Kreis, R. W.
July 2007
Journal of Bone & Joint Surgery, American Volume;Jul2007, Vol. 89-A Issue 7, p1424
Academic Journal
Background: Complex regional pain syndrome type I is treated symptomatically. A protective effect of vitamin C (ascorbic acid) has been reported previously. A dose-response study was designed to evaluate its effect in patients with wrist fractures. Methods: In a double-blind, prospective, multicenter trial, 416 patients with 427 wrist fractures were randomly allocated to treatment with placebo or treatment with 200, 500, or 1500 mg of vitamin C daily for fifty days. The effect of gender, age, fracture type, and cast-related complaints on the occurrence of complex regional pain syndrome was analyzed. Results: Three hundred and seventeen patients with 328 fractures were randomized to receive vitamin C, and ninety-nine patients with ninety-nine fractures were randomized to receive a placebo. The prevalence of complex regional pain syndrome was 2.4% (eight of 328) in the vitamin C group and 10.1% (ten of ninety-nine) in the placebo group (p = 0.002); all of the affected patients were elderly women. Analysis of the different doses of vitamin C showed that the prevalence of complex regional pain syndrome was 4.2% (four of ninety-six) in the 200-mg group (relative risk, 0.41; 95% confidence interval, 0.13 to 1.27), 1.8% (two of 114) in the 500-mg group (relative risk, 0.17; 95% confidence interval, 0.04 to 0.77), and 1.7% (two of 118) in the 1500-mg group (relative risk, 0.17; 95% confidence inter- val, 0.04 to 0.75). Early cast-related complaints predicted the development of complex regional pain syndrome (relative risk, 5.35; 95% confidence interval, 2.13 to 13.42). Conclusions: Vitamin C reduces the prevalence of complex regional pain syndrome after wrist fractures. A daily dose of 500 mg for fifty days is recommended. Level of Evidence: Therapeutic Level I. See Instructions to Authors for a complete description of levels of evidence.


Related Articles

  • No Higher Risk of CRPS After External Fixation of Distal Radial Fractures - Subgroup Analysis Under Randomised Vitamin C Prophylaxis. Zollinger, Paul E.; Kreis, Robert W.; van der Meulen, Hub G.; van der Elst, Maarten; Breederveld, Roelf S.; Tuinebreijer, Wim E. // Open Orthopaedics Journal;2010, Vol. 4, p71 

    Operative and conservative treatment of wrist fractures might lead to complex regional pain syndrome (CRPS) type I. In our multicenter dose response study in which patients with distal radial fractures were randomly allocated to placebo or vitamin C in a daily dose of 200mg, 500mg or 1500mg...

  • COMMENTARY: Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment. Jamal, Sophie A. // ACP Journal Club;Mar/Apr2005, Vol. 142 Issue 2, p44 

    The article comments on a study which examines the effects of etidronate, calcium, or placebo on bone mineral density (BMD) and fractures in patients taking oral or inhaled glucocorticoids or both for asthma. Patients randomized to etidronate had a 5% increase in lumbar spine BMD. No difference...

  • Vitamin C reduced the incidence of reflex sympathetic dystrophy after wrist fracture. Zollinger, P.E.; Tuinebreijer, W.E.; Kreis, R.W.; Breederveld, R.S. // Journal of Bone & Joint Surgery, American Volume;Jun2000, Vol. 82-A Issue 6, p873 

    Discusses the effect of vitamin C on frequency of reflex sympathetic dystrophy (RSD) in wrist fractures. Reduction of the incidence of post-traumatic RSD.

  • COMMENTARY. Rohekar, Sherry // Evidence Based Medicine;Apr2008, Vol. 13 Issue 2, p48 

    The article comments on the study by P. E. Zollinger and colleagues on the effectiveness of daily vitamin C in preventing development of complex regional pain syndrome (CRPS) in adults with wrist fractures. According to the author, the findings suggest that clinicians would need to treat only 12...

  • A controlled trial of L-tryptophan in mania. Chambers, C. A.; Naylor, G. J. // British Journal of Psychiatry;Jun78, Vol. 132, p555 

    A double-blind placebo-controlled trial of L-tryptophan, with pyridoxine and ascorbic acid, was carried out in 10 female patients suffering from mania. In contrast to earlier studies led by Prange and Murphy, L-tryptophan was found to be no better than placebo.

  • Once Yearly Vitamin D for Falls and Fractures: Not A Good Idea. Kiefer, David // Alternative Medicine Alert;Sep2011, Vol. 14 Issue 9, p103 

    Te aim of this study was to clarify some of the conflicting results in the literature about whether or not vitamin D supplementation can help to prevent falls or fractures. A variety of demographics and dosing regimens previously have been examined; the researchers behind this study chose a dose...

  • Post-exercise vitamin C supplementation and recovery from demanding exercise. Thompson, D.; Williams, C.; Garcia-Roves, P.; McGregor, S. J.; McArdle, F.; Jackson, M. J. // European Journal of Applied Physiology;May2003, Vol. 89 Issue 3/4, p393 

    The aim of this study was to investigate whether post-exercise vitamin C supplementation influences recovery from an unaccustomed bout of exercise. Sixteen male subjects were allocated to either a placebo (P; n=8) or vitamin C (VC) group (n=8). Subjects performed a prolonged (90-min)...

  • Osteoarthritis of the Knee with a Polyherbal Supplement and MSM with Vitamin C: A Randomized, Double-Blind, Placebo-Controlled Study. Haddad, Jack; Khano, Charlie; Poppay, Carol; Shinnick, Phillip // Townsend Letter;Jun2011, Issue 335, p68 

    The article presents study on the use of polyherbal supplement and methylsulfonylmethane (MSM) with Vitamin C for people with osteoarthritis (OA) of the knee. Products used in the study were supplied by Herbal Products and Development in Aptos, California including Flex-Connect Plus and MSM with...

  • Lower Extremity Purpura. Chang, Huan J. // JAMA: Journal of the American Medical Association;5/11/2011, Vol. 305 Issue 18, p1911 

    The article focuses on the case of a 50-year-old woman with lower extremity purpura. The patient, who has a history of heavy smoking with subsequent chronic obstructive pulmonary disease (COPD), was presented with a vasculitic-appearing cutaneous eruption of unknown duration. She was diagnosed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics